TipHub

₹27,725

▼ -181.39 -0.65%

As of 27 Jul 2026 · delayed

NSE Listed

Abbott India Limited (ABBOTINDIA)

Volume: 6,596Avg Vol 1W: 15,294.4Avg Vol 1M: 15,288.2552W Range:₹25,150₹35,310
NSE BSE www.abbott.co.in AI Report
Key Ratios
Checked 1d ago
Market Cap₹465 Cr
Current Price₹27,725
Previous Close₹27,906.39
High / Low (52w)₹35,310 / ₹25,150
Volume6,596
Avg Vol (1W)15,294.4
Avg Vol (1M)15,288.25
Stock P/E149.5
Book Value₹2,246.68
Dividend Yield4.2%
ROE37.9%
ROA33%
Revenue (TTM)₹7,217 Cr
Revenue Growth—
Profit Margin13.6%
Total Debt—
Shares Outstanding—
Face Value₹10
EPS (TTM)₹185.85
P/B12.37
Debt / Equity0.02
50 DMA₹26,633.9
200 DMA₹27,382.68
Day change-0.65%
Price Chart
₹27,725▼ 20.12% · 1Y
₹35195₹2518055K
2025-07-29
2026-07-27

20-day avg volume: 15K shares

Pros
  • Healthy return on equity of 37.9%.
  • Pays a dividend yield of 4.2%.
  • Company is almost debt-free.
Cons
  • Stock trades at a high P/E of 150.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹1,558 Cr₹1,633 Cr₹1,614 Cr₹1,605 Cr₹1,738 Cr₹1,757 Cr₹1,724 Cr₹1,710 Cr
EBITDA₹440 Cr₹482 Cr₹490 Cr₹487 Cr₹499 Cr₹553 Cr₹514 Cr₹537 Cr
Net Profit₹328 Cr₹359 Cr₹361 Cr₹367 Cr₹366 Cr₹415 Cr₹376 Cr₹395 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹3,792 Cr₹4,208 Cr₹4,391 Cr₹4,996 Cr₹5,503 Cr₹6,097 Cr₹6,685 Cr₹7,217 Cr
EBITDA₹701 Cr₹811 Cr₹944 Cr₹1,099 Cr₹1,290 Cr₹1,630 Cr₹1,898 Cr₹2,104 Cr
Net Profit₹450 Cr₹593 Cr₹691 Cr₹799 Cr₹949 Cr₹1,201 Cr₹1,414 Cr₹1,552 Cr
EPS211.93279.04325.04375.87446.8565.28665.62730.36
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹2,941 Cr₹3,547 Cr₹3,840 Cr₹4,224 Cr₹4,556 Cr₹5,193 Cr₹5,917 Cr₹6,502 Cr
Total Liabilities₹932 Cr₹1,115 Cr₹1,238 Cr₹1,404 Cr₹1,367 Cr₹1,495 Cr₹1,684 Cr₹1,728 Cr
Equity₹2,009 Cr₹2,432 Cr₹2,602 Cr₹2,820 Cr₹3,189 Cr₹3,699 Cr₹4,233 Cr₹4,774 Cr
Total Debt————————
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹855 Cr₹962 Cr₹1,237 Cr₹1,234 Cr₹1,617 Cr₹1,459 Cr₹1,859 Cr
Investing₹-401 Cr₹-72 Cr₹-396 Cr₹-148 Cr₹-416 Cr₹182 Cr₹-371 Cr
Financing₹-217 Cr₹-582 Cr₹-637 Cr₹-639 Cr₹-745 Cr₹-925 Cr₹-1,066 Cr
Free Cash Flow₹855 Cr₹962 Cr₹1,237 Cr₹1,234 Cr₹1,617 Cr₹1,459 Cr₹1,859 Cr
Shareholding
Promoter 74.99% Institutions 9.16% Public 15.85%
Efficiency & Working Capital
ROCE45%
Interest Coverage655
Dividend Payout—
Debtor Days19 d
Inventory Days50 d
Payable Days58 d
Cash Conversion Cycle11 d
Working Capital Days69 d
Shareholding Details

As of 2026-06-30

Promoter75%
FII0.4%
DII8.8%
Institutions9.2%
Public15.9%
Promoter Pledge0%
No. of Shareholders78,320
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters75%75%75%75%75%75%75%75%75%75%75%75%
FIIs0.2%0.2%0.2%0.2%0.2%0.2%0.2%0.2%0.2%0.2%0.3%0.4%
DIIs8.7%8.7%8.9%8.8%9%9%8.9%9.2%9.1%9%8.9%8.8%
Public16.1%16.1%15.9%16%15.9%15.8%15.9%15.7%15.7%15.8%15.8%15.9%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders68,88572,25269,38271,58869,44967,89269,93467,58471,19975,80175,86678,320
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Abbott Capital India LimitedShareholding of Promoter and Promoter Group50.4%1.07 Cr
Abbott Healthcare Products LimitedShareholding of Promoter and Promoter Group17.6%37,44,951
British Colloids LimitedShareholding of Promoter and Promoter Group6.9%14,70,000
Sbi Nifty Midcap 150 Momentum 50 EtfPublic Shareholding1.9%4,07,689
Canara Robeco Mutual FundPublic Shareholding1.1%2,27,197
Nippon Life India Trustee LtdPublic Shareholding1.1%2,28,098
Board of Directors
NameDesignationYear
Munir ShaikhChairman(Non Exe)&Dir(Non-Ind)2026
Kartik RajendranExecutive Director & MD2026
Kaiyomarz MarfatiaNon-Exec & Non-Independent Dir2026
Vivek MohanNon-Exec & Non-Independent Dir2026
Darshan GadaNon-Exec & Non-Independent Dir2026
James WennerNon Executive Director2026
Sudarshan JainIndependent Non Exe. Director2026
Shalini KamathIndependent Non Exe. Director2026
Neeraj JainIndependent Non Exe. Director2026
Sangeeta ShettyCompany Sec. & Compli. Officer2026
Segments — Product
SegmentRevenueShare
Pharmaceuticals₹0 Cr—
Segments — Geography
RegionRevenueShare
India₹6,764 Cr98.8%
Outside India₹82 Cr1.2%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10282121
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-24Dividend (131/- per share)Special
forthcoming2026-07-24Dividend (525/- per share)Final
dividend2026-07-24₹525 (5250%)Final
dividend2026-07-24₹131 (1310%)Special
dividend2025-07-25₹475 (4750%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20251,098001101,568
2025000004
20252140000653
Company Information
Incorporated1944
ChairmanMunir Shaikh
AuditorWalker Chandiok & Co LLP
Investor Email[email protected]; webmaster@abbo
🌐 www.abbott.co.in ↗

📍 Unit No 3 Corporate Park, Sion Trombay Road Chembur, Mumbai, Maharashtra, 400071

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Aatmaj Healthcare LimitedAavas Financiers LimitedAayush Wellness LimitedAban Offshore Ltd.Abans Enterprises Ltd.ABB India LimitedAditya Birla Capital Ltd.ABCL SR IIABCL SR IVA B Cotspin India LimitedABCL FBIL LINK2027 SR K3ABCL FBIL 2028 SR F3All “A” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search